Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology

Aurelie Morand,Amandine Weill,Juliette Miquel,Olivier Chosidow,Bernard Guillot,Julio Tannous,Ludovic de Gentile,Emmanuel Parant,Béatrice Quinet,Marie Boyer,Annabel Maruani,Nathalie Bodak,Alice Phan,Arezki Izri,Barthélémy Tosello,Florence Bretelle,Elisabeth Elefant,Franck Boralevi,Catherine Letord,Thomas Hubiche,Stephanie Mallet
DOI: https://doi.org/10.1093/bjd/ljae288
IF: 11.113
2024-07-19
British Journal of Dermatology
Abstract:Although scabies is a common disease, questions concerning efficacy, safety, tolerance and galenic formulation persist, in particular regarding its treatment in young children under 15 kg and in pregnant or breastfeeding women. This manuscript reports the recommendations developed by the Centre of Evidence of the French Society of Dermatology. IVM can be proposed as first-line treatment from 2 years on, especially if in doubt about compliance or damaged skin, or in grouped cases; IVM can also be proposed as second-line treatment, if necessary, after 2 months.
dermatology
What problem does this paper attempt to address?